Stock Traders Buy High Volume of Evelo Biosciences Put Options (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLOGet Free Report) saw unusually large options trading activity on Wednesday. Investors purchased 1,885 put options on the stock. This represents an increase of 1,101% compared to the typical volume of 157 put options.

Evelo Biosciences Stock Performance

Shares of NASDAQ:EVLO opened at $0.00 on Thursday. The company has a fifty day moving average of $0.01 and a 200-day moving average of $0.04. The company has a market capitalization of $3,796.60, a PE ratio of 0.00 and a beta of 1.58. Evelo Biosciences has a 52-week low of $0.00 and a 52-week high of $0.76.

About Evelo Biosciences

(Get Free Report)

Evelo Biosciences, Inc, a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.

See Also

Receive News & Ratings for Evelo Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evelo Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.